On 16 October 2026, the European Securities and Markets Authority (ESMA) published its Final Report on revised Guidelines concerning the delayed disclosure of inside information under the Market Abuse Regulation (MAR). The revisions align the Guidelines with the changes introduced by the EU Listing Act and provide further clarity on when issuers may delay disclosure. These revisions complete the updated MAR disclosure framework, following the changes to protracted processes and the revised conditions for delaying disclosure we have previously covered.
What has changed?
Removal of previous legitimate interests
Under the Listing Act amendments to MAR, which became applicable on 5 June 2026, issuers are generally no longer required to disclose inside information relating to intermediate steps in protracted processes. Instead, only the final event or circumstance must be disclosed as soon as possible after it occurs.
As a result, ESMA has removed several previously recognised legitimate interests for delaying disclosure, including those relating to ongoing negotiations, mergers and acquisitions, and other protracted processes. Since intermediate steps in these processes are no longer generally subject to immediate disclosure requirements, issuers do not need to rely on the delayed disclosure mechanism for such information. In total, ESMA has deleted seven of the previous examples, which also covered approvals by corporate bodies, inventions and own funds instruments, as it considers them now covered by the rules on protracted processes.
New legitimate interests for delayed disclosure
To reflect the revised framework, ESMA has introduced five additional examples of legitimate interests that may justify delaying the disclosure of inside information:
- Public authority orders: Where an issuer is required by a public authority to maintain confidentiality.
- Exceptional events: Where additional time is needed to gather information following an incident, such as a cyberattack, to enable an accurate initial disclosure.
- Commercially sensitive information: Where disclosure could directly jeopardise a concrete business opportunity, including competitive tender processes or market-entry strategies.
- Management appointments: Where announcing the appointment of a key executive or board member could jeopardise the appointment, for example because the individual has not yet informed their current employer.
- Intra-group disclosures: Where disclosure by one group company would directly prejudice the issuer and undermine a lawful disclosure delay applied by another company within the same group.
The final two examples were added following ESMA’s public consultation. ESMA has also retained and clarified the existing legitimate interest concerning serious financial distress.
Removal of the previous “misleading the public” Guideline
ESMA has also removed its previous Guideline on situations where delayed disclosure is likely to mislead the public. This follows the Listing Act’s amendment of Article 17(4)(b) MAR, which replaced the condition that delayed disclosure must not be likely to mislead the public with a more specific requirement: the inside information the issuer intends to delay must not be in contrast with its latest public announcement or other communication on the same matter. ESMA has deleted this Guideline entirely, as its mandate no longer covers it following the Listing Act.
The corresponding situations are now addressed in Annex II of Commission Delegated Regulation (EU) 2026/789, which provides a non-exhaustive list of situations in which inside information is in contrast with the issuer’s latest public announcement or other communication on the same matter.
What does this mean for issuers?
The revised Guidelines provide greater clarity on when delayed disclosure may be justified under the amended MAR framework. However, the list of legitimate interests remains non-exhaustive, and the existence of a legitimate interest does not automatically permit a delay.
Issuers must continue to satisfy all conditions under Article 17(4) MAR, including maintaining confidentiality and ensuring that the inside information they intend to delay is not in contrast with their latest public announcement or other communication on the same matter.
It is also worth remembering that the main change comes from the Listing Act itself rather than the Guidelines, and that it relieves only the disclosure obligation under Article 17. Information on intermediate steps in a protracted process can still be inside information, so the prohibition on unlawful disclosure under Article 14 and the obligation to keep insider lists under Article 18 continue to apply.
In practice, the new contrast test asks issuers to compare the inside information with what they themselves have said publicly on the same matter. “Communication” is defined broadly in Annex III of the Delegated Regulation: beyond press releases and regulatory filings, it can include social media posts, podcasts, webinars, roadshows, advertising campaigns and public interviews, when made by the issuer or a person formally representing it. Issuers may therefore want to consider:
- Keeping a searchable record of public statements by topic, such as forecasts, guidance, targets, strategy and governance, across all channels – not only press releases.
- Documenting the comparison with the latest public statement on the matter before any decision to delay disclosure. If the inside information is in contrast with that statement, disclosure cannot be delayed.
- Briefing spokespeople and investor relations teams, as an informal remark in a podcast or at a roadshow can become the latest communication on a matter.
The revised Guidelines will become applicable once published on ESMA’s website in all 24 official EU languages. National competent authorities then have two months to confirm whether they comply. Based on how long translations took for previous versions of the Guidelines, publication could follow in early 2027. For an overview of all the Listing Act changes to MAR and when they apply, see our article on the EU Listing Act’s implications for MAR and insider lists.
As insider list obligations continue to apply, see how Logwise helps issuers keep insider lists accurate and up to date with Insider List Management.
Source: ESMA Final Report – MAR Guidelines on delay in the disclosure of inside information, 16 October 2026 (ESMA74-268544963-1718).
Security update: PHP2Shell vulnerabilities
On 21 October 2026, two critical security vulnerabilities affecting PHP were publicly disclosed, commonly referred to as PHP2Shell (CVE-2026-109618 and CVE-2026-109619). These vulnerabilities could allow attackers to compromise affected web servers. The […]
Security update: PHP2Shell vulnerabilities
On 21 October 2026, two critical security vulnerabilities affecting PHP were publicly disclosed, commonly referred to as PHP2Shell (CVE-2026-109618 and CVE-2026-109619). These vulnerabilities could allow attackers to compromise affected web servers. The […]
EU Listing Act – Implications for MAR and Insider Lists
The Act was published 14 November 2024 and entered into force on 4 December 2024. Its changes to MAR are rolled out in two waves, with three different effective dates: 4 December […]
EU Listing Act – Implications for MAR and Insider Lists – 4 December 2024
The Act was published 14 November 2024 and entered into force on 4 December 2024. Its changes to MAR are rolled out in two waves, with two different effective dates: 4 December […]
Revised Conditions for Delaying Disclosure
The delay mechanism (under Art. 17(4)) is retained, but one of the three conditions has been amended. The previous condition – that delay is “not likely to mislead the public” – is […]
